Plastic production has outgrown most other manmade materials, with more than 90% being petroleum-based and nonbiodegradable. Packaging, primarily food packaging, consumes the most plastic and is the largest contributor to municipal solid waste. In addition, its dependence on crude oil feedstock makes the plastic industry unsustainable and renders plastic markets vulnerable to oil price volatility. Therefore, the development of bioalternatives to conventional plastics is now a priority of the food packaging industry. Bioplastics are polymers that are either biobased (fully or partially), or biodegradable, or both. This review aims to provide an insightful overview of the most recent research and development successes in bioplastic materials, focusing on food packaging applications. Bioplastics are compared to their conventional counterparts with respect to their mechanical, thermal, barrier, and processability properties. The gaps between bio-and conventional plastics in food packaging are elucidated. Potential avenues for improving bioplastic properties to broaden their food packaging applications are critically examined. Furthermore, two of the most controversial topics on bioplastic alternatives, sustainability assessment and their impact on the plastic waste management system, are discussed.

No abstract

Seventeen Ohio soybeans were screened for isoflavone content and antioxidant activity. Isoflavone content was determined by C(18) reversed phase high-performance liquid chromatography coupled with a photodiode array detector. Antioxidant activities of soybean extracts were measured using 2,2-diphenyl-1-picryl-hydrazyl (DPPH) free radical and photochemiluminescence (PCL) methods. The highest and lowest total isoflavone contents were 11.75 and 4.20 micromol/g soy, respectively, while the average was 7.12 micromol/g soy. Antioxidant activities of soybean extracts ranged from 7.51 to 12.18 micromol butylated hydroxytoluene (BHT) equivalent/g soy using the DPPH method. Lipid and water soluble antioxidant activities of soybean extracts ranged from 2.40 to 4.44 micromol Trolox equivalent/g soy and from 174.24 to 430.86 micromol ascorbic acid equivalent/g soy, respectively, using the PCL method.

Adult wound repair occurs with an initial inflammatory response, reepithelialization, and the formation of a permanent scar. Although the inflammatory phase is often considered a necessity for successful adult wound healing, fetal healing studies have shown the ability to regenerate skin and to heal wounds in a scarless manner in the absence of inflammation. The cyclooxygenase-2 (COX-2) enzyme, a known mediator of inflammation, has been shown to contribute to a variety of inflammatory conditions and to the development of cancer in many organs. To examine the role of COX-2 in the wound healing process, incisional wounds were treated topically with the anti-inflammatory COX-2 inhibitor celecoxib. Acutely, celecoxib inhibited several parameters of inflammation in the wound site. This decrease in the early inflammatory phase of wound healing had a significant effect on later events in the wound healing process, namely a reduction in scar tissue formation, without disrupting reepithelialization or decreasing tensile strength. Our data suggest that in the absence of infection, adult wound healing is able to commence with decreased inflammation and that anti-inflammatory drugs may be used to improve the outcome of the repair process in the skin by limiting scar formation.

No abstract